CVS

CVS Health Corp.

Fundamental data last updated:July 22, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Healthcare

industry

Medical - Healthcare Plans

Exchange

NYSE

County of HQ

US

Next Earnings Date

08/05/2026

Business Summary

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

 


Analyze CVS on TradingView

VALUATION

P/E

44.32

Market Cap ($M USD)

$130.25B

Forward P/E

8.37

PEG

0.02

PRICE TO SALES

0.32

PRICE TO BOOK

1.68

EV / EBITDA

17.88

5-Year Average P/E

Free Cash Flow Yield

5.68%

DCF Value

$377.71

Graham Number

$56.15

Price to FCF

17.62

EV to FCF

26.92

Earnings Yield

2.26%

FCF Yield

5.68%

DIVIDEND

Yield

2.61%

Annual Payout

$2.66

Payout Ratio

116.10%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$2.30

Next Year EPS Growth Estimate

$12.20

Next Year Revenue Growth Estimate

$49.87T

Return on Equity (ROE)

3.87%

FREE CASH FLOW

Operating Margin

1.46%

Debt-to-Equity

1.24

Piotroski F-Score

7

Altman Z-Score

2.44

Return on Invested Capital (ROIC)

3.58%

Current Ratio

0.87

Quick Ratio

0.66

Net Debt to EBITDA

6.18

Interest Coverage

1.92

Gross Profit margin

13.87%

FCF PER SHARE

$5.81

REVENUE PER SHARE

$320.43

Analyze CVS on TradingView

Gainseekers Quantitative Analysis

Summary

CVS Health Corporation’s valuation presents a striking disconnect. The stock has traded significantly below its DCF value, suggesting a potential deep value opportunity. With a Forward P/E of 7.96, the market seems to underestimate its future earnings potential. However, the Altman Z-score of 2.39 indicates moderate financial distress, and the Earnings Yield of 2.49% is underwhelming. This paints a picture of a company with undervalued growth prospects but lingering financial vulnerabilities.

AI Exposure / Tech Reliance

Operating in the healthcare sector, CVS is strategically positioned to leverage AI and tech advancements. As a major player in healthcare plans, integrating AI could enhance patient care and operational efficiency. This adaptability is crucial for maintaining a competitive edge in a rapidly evolving industry.

The Bull Case

For value or GARP investors, CVS offers compelling reasons to buy. The company boasts a solid Piotroski F-Score of 7, indicating strong financial health. Its ROIC of 3.58% and FCF Yield of 6.27% suggest efficient capital allocation and robust cash generation. These metrics highlight CVS's ability to maintain pricing power and operational efficiency, making it an attractive investment.

The Bear Case

Despite its strengths, CVS faces significant structural risks. The Price/Book ratio of 1.52 and Price/Sales ratio of 0.29 suggest that the stock might be overvalued relative to its book and sales figures. Additionally, the stock's proximity to its 52-week high raises concerns about technical overextension. The low Operating Margin of 1.46% further underscores potential profitability challenges.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$103.58

Institutional Ownership %

1-Year Beta

0.60

Insider Buying % (6 Mo)

Distance to 52-Week High

3.99%

Distance to 52-Week Low

42.69%

EARNINGS SURPRISE %

17.89%

50-DAY SMA

$93.93

200-DAY SMA

$81.72

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.